Correlation Between Tarsus Pharmaceuticals and Ikena Oncology
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Ikena Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Ikena Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and Ikena Oncology, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Ikena Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Ikena Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Ikena Oncology.
Diversification Opportunities for Tarsus Pharmaceuticals and Ikena Oncology
-0.27 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Tarsus and Ikena is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Ikena Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ikena Oncology and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Ikena Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ikena Oncology has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Ikena Oncology go up and down completely randomly.
Pair Corralation between Tarsus Pharmaceuticals and Ikena Oncology
Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 1.72 times more return on investment than Ikena Oncology. However, Tarsus Pharmaceuticals is 1.72 times more volatile than Ikena Oncology. It trades about 0.21 of its potential returns per unit of risk. Ikena Oncology is currently generating about -0.05 per unit of risk. If you would invest 2,617 in Tarsus Pharmaceuticals on November 2, 2024 and sell it today you would earn a total of 2,557 from holding Tarsus Pharmaceuticals or generate 97.71% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Tarsus Pharmaceuticals vs. Ikena Oncology
Performance |
Timeline |
Tarsus Pharmaceuticals |
Ikena Oncology |
Tarsus Pharmaceuticals and Ikena Oncology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Tarsus Pharmaceuticals and Ikena Oncology
The main advantage of trading using opposite Tarsus Pharmaceuticals and Ikena Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Ikena Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ikena Oncology will offset losses from the drop in Ikena Oncology's long position.Tarsus Pharmaceuticals vs. Aldeyra | Tarsus Pharmaceuticals vs. Travere Therapeutics | Tarsus Pharmaceuticals vs. Eton Pharmaceuticals | Tarsus Pharmaceuticals vs. Connect Biopharma Holdings |
Ikena Oncology vs. Edgewise Therapeutics | Ikena Oncology vs. Design Therapeutics | Ikena Oncology vs. Xilio Development | Ikena Oncology vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |